pyrazolo(3,4-d)pyrimidine has been researched along with Inflammation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheong, CS; Han, SH; Hwang, O; Kim, DJ; Kim, HR; Lee, JA; Shin, N; Son, HJ | 1 |
Abd-El-Aziz, AS; Abdelghani, AA; Al Sorkhy, M; Al-Harbi, KB; Almundarij, TI; Alrawashdeh, S; Atatreh, N; El-Ashmawy, IM; Ghattas, MA; Youssef, AM | 1 |
2 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Inflammation
Article | Year |
---|---|
A novel pyrazolo [3,4-d] pyrimidine, KKC080106, activates the Nrf2 pathway and protects nigral dopaminergic neurons.
Topics: Animals; Antioxidants; Brain; Cytokines; Dopaminergic Neurons; Inflammation; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; NF-E2-Related Factor 2; Nitric Oxide; Phosphorylation; Protein Kinases; Pyrazoles; Pyrimidines; Sambucus nigra; Signal Transduction | 2020 |
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Granuloma; Humans; Inflammation; Male; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Recombinant Proteins; Structure-Activity Relationship; Turpentine | 2019 |